APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Ketorolac Tromethamine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Ketorolac Tromethamine Market Outlook and Growth Opportunities 2026

Report ID 174005660422 December 2025196 pages

Choose your research edition.

Industry ResearchKetorolac Tromethamine Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Ketorolac Tromethamine Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Ketorolac Tromethamine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ketorolac Tromethamine Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Ketorolac Tromethamine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Ketorolac Tromethamine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Ketorolac Tromethamine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ketorolac Tromethamine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ketorolac Tromethamine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Ketorolac Tromethamine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Ketorolac Tromethamine market include Teva, Sun Pharmaceutical, Sandoz, Mylan, Pfizer, Sagent Pharmaceuticals, Omeros Corporation, Gland Pharma Limited and Egalet US Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Ketorolac Tromethamine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ketorolac Tromethamine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ketorolac Tromethamine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ketorolac Tromethamine market size, projected growth trends, production technologies, key applications, and end-use industries.

Ketorolac Tromethamine Segment by Company

Teva

Sun Pharmaceutical

Sandoz

Mylan

Pfizer

Sagent Pharmaceuticals

Omeros Corporation

Gland Pharma Limited

Egalet US Inc.

Dr. Reddy’s Laboratories

Aurobindo Pharma

Apotex

Amphastar Pharmaceuticals

Allergan

Akorn

Ketorolac Tromethamine Segment by Type

Nasal

Oral tablet

Ophthalmic

Injection

Ketorolac Tromethamine Segment by Application

Hospital

Clinic

Others

Ketorolac Tromethamine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Ketorolac Tromethamine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Ketorolac Tromethamine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Ketorolac Tromethamine significant trends, drivers, influence factors in global and regions.

6. To analyze Ketorolac Tromethamine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ketorolac Tromethamine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ketorolac Tromethamine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ketorolac Tromethamine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Ketorolac Tromethamine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ketorolac Tromethamine industry.

Chapter 3: Detailed analysis of Ketorolac Tromethamine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Ketorolac Tromethamine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Ketorolac Tromethamine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Ketorolac Tromethamine Industry Trends Table 2. Ketorolac Tromethamine Industry Drivers Table 3. Ketorolac Tromethamine Industry Opportunities and Challenges Table 4. Ketorolac Tromethamine Industry Restraints Table 5. Global Ketorolac Tromethamine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Ketorolac Tromethamine Revenue Share by Company (2021-2026) Table 7. Global Ketorolac Tromethamine Sales Volume by Company (k units) & (2021-2026) Table 8. Global Ketorolac Tromethamine Sales Volume Share by Company (2021-2026) Table 9. Global Ketorolac Tromethamine Average Price (US$/unit) of Company (2021-2026) Table 10. Global Ketorolac Tromethamine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Ketorolac Tromethamine Key Company Manufacturing Base & Headquarters Table 12. Global Ketorolac Tromethamine Company, Product Type & Application Table 13. Global Ketorolac Tromethamine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Ketorolac Tromethamine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Nasal Table 18. Significant Companies of Oral tablet Table 19. Significant Companies of Ophthalmic Table 20. Significant Companies of Injection Table 21. Global Ketorolac Tromethamine Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Ketorolac Tromethamine Sales Volume by Type (2021-2026) & (k units) Table 23. Global Ketorolac Tromethamine Sales Volume by Type (2027-2032) & (k units) Table 24. Global Ketorolac Tromethamine Sales Volume Share by Type (2021-2026) Table 25. Global Ketorolac Tromethamine Sales Volume Share by Type (2027-2032) Table 26. Global Ketorolac Tromethamine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Ketorolac Tromethamine Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Ketorolac Tromethamine Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Ketorolac Tromethamine Sales Value Share by Type (2021-2026) Table 30. Global Ketorolac Tromethamine Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Hospital Table 32. Significant Companies of Clinic Table 33. Significant Companies of Others Table 34. Global Ketorolac Tromethamine Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Ketorolac Tromethamine Sales Volume by Application (2021-2026) & (k units) Table 36. Global Ketorolac Tromethamine Sales Volume by Application (2027-2032) & (k units) Table 37. Global Ketorolac Tromethamine Sales Volume Share by Application (2021-2026) Table 38. Global Ketorolac Tromethamine Sales Volume Share by Application (2027-2032) Table 39. Global Ketorolac Tromethamine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Ketorolac Tromethamine Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Ketorolac Tromethamine Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Ketorolac Tromethamine Sales Value Share by Application (2021-2026) Table 43. Global Ketorolac Tromethamine Sales Value Share by Application (2027-2032) Table 44. Global Ketorolac Tromethamine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Ketorolac Tromethamine Sales by Region (2021-2026) & (k units) Table 46. Global Ketorolac Tromethamine Sales Market Share by Region (2021-2026) Table 47. Global Ketorolac Tromethamine Sales by Region (2027-2032) & (k units) Table 48. Global Ketorolac Tromethamine Sales Market Share by Region (2027-2032) Table 49. Global Ketorolac Tromethamine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Ketorolac Tromethamine Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Ketorolac Tromethamine Sales Value Share by Region (2021-2026) Table 52. Global Ketorolac Tromethamine Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Ketorolac Tromethamine Sales Value Share by Region (2027-2032) Table 54. Global Ketorolac Tromethamine Market Average Price (US$/unit) by Region (2021-2026) Table 55. Global Ketorolac Tromethamine Market Average Price (US$/unit) by Region (2027-2032) Table 56. Global Ketorolac Tromethamine Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Global Ketorolac Tromethamine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Ketorolac Tromethamine Sales by Country (2021-2026) & (k units) Table 59. Global Ketorolac Tromethamine Sales Market Share by Country (2021-2026) Table 60. Global Ketorolac Tromethamine Sales by Country (2027-2032) & (k units) Table 61. Global Ketorolac Tromethamine Sales Market Share by Country (2027-2032) Table 62. Global Ketorolac Tromethamine Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Ketorolac Tromethamine Sales Value Market Share by Country (2021-2026) Table 64. Global Ketorolac Tromethamine Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Ketorolac Tromethamine Sales Value Market Share by Country (2027-2032) Table 66. Teva Company Information Table 67. Teva Business Overview Table 68. Teva Ketorolac Tromethamine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Teva Ketorolac Tromethamine Product Portfolio Table 70. Teva Recent Development Table 71. Sun Pharmaceutical Company Information Table 72. Sun Pharmaceutical Business Overview Table 73. Sun Pharmaceutical Ketorolac Tromethamine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Sun Pharmaceutical Ketorolac Tromethamine Product Portfolio Table 75. Sun Pharmaceutical Recent Development Table 76. Sandoz Company Information Table 77. Sandoz Business Overview Table 78. Sandoz Ketorolac Tromethamine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Sandoz Ketorolac Tromethamine Product Portfolio Table 80. Sandoz Recent Development Table 81. Mylan Company Information Table 82. Mylan Business Overview Table 83. Mylan Ketorolac Tromethamine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Mylan Ketorolac Tromethamine Product Portfolio Table 85. Mylan Recent Development Table 86. Pfizer Company Information Table 87. Pfizer Business Overview Table 88. Pfizer Ketorolac Tromethamine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Pfizer Ketorolac Tromethamine Product Portfolio Table 90. Pfizer Recent Development Table 91. Sagent Pharmaceuticals Company Information Table 92. Sagent Pharmaceuticals Business Overview Table 93. Sagent Pharmaceuticals Ketorolac Tromethamine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Sagent Pharmaceuticals Ketorolac Tromethamine Product Portfolio Table 95. Sagent Pharmaceuticals Recent Development Table 96. Omeros Corporation Company Information Table 97. Omeros Corporation Business Overview Table 98. Omeros Corporation Ketorolac Tromethamine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Omeros Corporation Ketorolac Tromethamine Product Portfolio Table 100. Omeros Corporation Recent Development Table 101. Gland Pharma Limited Company Information Table 102. Gland Pharma Limited Business Overview Table 103. Gland Pharma Limited Ketorolac Tromethamine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Gland Pharma Limited Ketorolac Tromethamine Product Portfolio Table 105. Gland Pharma Limited Recent Development Table 106. Egalet US Inc. Company Information Table 107. Egalet US Inc. Business Overview Table 108. Egalet US Inc. Ketorolac Tromethamine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Egalet US Inc. Ketorolac Tromethamine Product Portfolio Table 110. Egalet US Inc. Recent Development Table 111. Dr. Reddy’s Laboratories Company Information Table 112. Dr. Reddy’s Laboratories Business Overview Table 113. Dr. Reddy’s Laboratories Ketorolac Tromethamine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Dr. Reddy’s Laboratories Ketorolac Tromethamine Product Portfolio Table 115. Dr. Reddy’s Laboratories Recent Development Table 116. Aurobindo Pharma Company Information Table 117. Aurobindo Pharma Business Overview Table 118. Aurobindo Pharma Ketorolac Tromethamine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Aurobindo Pharma Ketorolac Tromethamine Product Portfolio Table 120. Aurobindo Pharma Recent Development Table 121. Apotex Company Information Table 122. Apotex Business Overview Table 123. Apotex Ketorolac Tromethamine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Apotex Ketorolac Tromethamine Product Portfolio Table 125. Apotex Recent Development Table 126. Amphastar Pharmaceuticals Company Information Table 127. Amphastar Pharmaceuticals Business Overview Table 128. Amphastar Pharmaceuticals Ketorolac Tromethamine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Amphastar Pharmaceuticals Ketorolac Tromethamine Product Portfolio Table 130. Amphastar Pharmaceuticals Recent Development Table 131. Allergan Company Information Table 132. Allergan Business Overview Table 133. Allergan Ketorolac Tromethamine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. Allergan Ketorolac Tromethamine Product Portfolio Table 135. Allergan Recent Development Table 136. Akorn Company Information Table 137. Akorn Business Overview Table 138. Akorn Ketorolac Tromethamine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 139. Akorn Ketorolac Tromethamine Product Portfolio Table 140. Akorn Recent Development Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. Ketorolac Tromethamine Distributors List Table 144. Ketorolac Tromethamine Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Ketorolac Tromethamine Product Image Figure 2. Global Ketorolac Tromethamine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ketorolac Tromethamine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Ketorolac Tromethamine Sales (2021-2032) & (k units) Figure 5. Global Ketorolac Tromethamine Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Ketorolac Tromethamine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Nasal Image Figure 10. Oral tablet Image Figure 11. Ophthalmic Image Figure 12. Injection Image Figure 13. Global Ketorolac Tromethamine Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Ketorolac Tromethamine Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Ketorolac Tromethamine Sales Volume Share by Type (2021-2032) Figure 16. Global Ketorolac Tromethamine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Ketorolac Tromethamine Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Ketorolac Tromethamine Sales Value Share by Type (2021-2032) Figure 19. Hospital Image Figure 20. Clinic Image Figure 21. Others Image Figure 22. Global Ketorolac Tromethamine Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Ketorolac Tromethamine Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Ketorolac Tromethamine Sales Volume Share by Application (2021-2032) Figure 25. Global Ketorolac Tromethamine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Ketorolac Tromethamine Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Ketorolac Tromethamine Sales Value Share by Application (2021-2032) Figure 28. Global Ketorolac Tromethamine Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 29. Global Ketorolac Tromethamine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Ketorolac Tromethamine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Ketorolac Tromethamine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Ketorolac Tromethamine Sales Value (2021-2032) & (US$ Million) Figure 33. North America Ketorolac Tromethamine Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Ketorolac Tromethamine Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Ketorolac Tromethamine Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Ketorolac Tromethamine Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Ketorolac Tromethamine Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Ketorolac Tromethamine Sales Value (2021-2032) & (US$ Million) Figure 39. South America Ketorolac Tromethamine Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Ketorolac Tromethamine Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Ketorolac Tromethamine Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Ketorolac Tromethamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Ketorolac Tromethamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Ketorolac Tromethamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Ketorolac Tromethamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Ketorolac Tromethamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Ketorolac Tromethamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Ketorolac Tromethamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Ketorolac Tromethamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Ketorolac Tromethamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Ketorolac Tromethamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Ketorolac Tromethamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Ketorolac Tromethamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Ketorolac Tromethamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Ketorolac Tromethamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Ketorolac Tromethamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Ketorolac Tromethamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Ketorolac Tromethamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Ketorolac Tromethamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Ketorolac Tromethamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Ketorolac Tromethamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Ketorolac Tromethamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Ketorolac Tromethamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Ketorolac Tromethamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Ketorolac Tromethamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Ketorolac Tromethamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Ketorolac Tromethamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Ketorolac Tromethamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Ketorolac Tromethamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Ketorolac Tromethamine Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Ketorolac Tromethamine Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Nasal
  • Oral tablet
  • Ophthalmic
  • Injection
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Teva
  • Sun Pharmaceutical
  • Sandoz
  • Mylan
  • Pfizer
  • Sagent Pharmaceuticals
  • Omeros Corporation
  • Gland Pharma Limited
  • Egalet US Inc.
  • Dr. Reddy’s Laboratories
  • Aurobindo Pharma
  • Apotex
  • Amphastar Pharmaceuticals
  • Allergan
  • Akorn

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ketorolac Tromethamine Sales Value (2021-2032)
  4. 1.2.2 Global Ketorolac Tromethamine Sales Volume (2021-2032)
  5. 1.2.3 Global Ketorolac Tromethamine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Ketorolac Tromethamine Market Dynamics
  1. 2.1 Ketorolac Tromethamine Industry Trends
  2. 2.2 Ketorolac Tromethamine Industry Drivers
  3. 2.3 Ketorolac Tromethamine Industry Opportunities and Challenges
  4. 2.4 Ketorolac Tromethamine Industry Restraints
3 Ketorolac Tromethamine Market by Company
  1. 3.1 Global Ketorolac Tromethamine Company Revenue Ranking in 2025
  2. 3.2 Global Ketorolac Tromethamine Revenue by Company (2021-2026)
  3. 3.3 Global Ketorolac Tromethamine Sales Volume by Company (2021-2026)
  4. 3.4 Global Ketorolac Tromethamine Average Price by Company (2021-2026)
  5. 3.5 Global Ketorolac Tromethamine Company Ranking (2024-2026)
  6. 3.6 Global Ketorolac Tromethamine Company Manufacturing Base and Headquarters
  7. 3.7 Global Ketorolac Tromethamine Company Product Type and Application
  8. 3.8 Global Ketorolac Tromethamine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Ketorolac Tromethamine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Ketorolac Tromethamine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Ketorolac Tromethamine Market by Type
  1. 4.1 Ketorolac Tromethamine Type Introduction
  2. 4.1.1 Nasal
  3. 4.1.2 Oral tablet
  4. 4.1.3 Ophthalmic
  5. 4.1.4 Injection
  6. 4.2 Global Ketorolac Tromethamine Sales Volume by Type
  7. 4.2.1 Global Ketorolac Tromethamine Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Ketorolac Tromethamine Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Ketorolac Tromethamine Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Ketorolac Tromethamine Sales Value by Type
  11. 4.3.1 Global Ketorolac Tromethamine Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Ketorolac Tromethamine Sales Value by Type (2021-2032)
  13. 4.3.3 Global Ketorolac Tromethamine Sales Value Share by Type (2021-2032)
5 Ketorolac Tromethamine Market by Application
  1. 5.1 Ketorolac Tromethamine Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Ketorolac Tromethamine Sales Volume by Application
  6. 5.2.1 Global Ketorolac Tromethamine Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ketorolac Tromethamine Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Ketorolac Tromethamine Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Ketorolac Tromethamine Sales Value by Application
  10. 5.3.1 Global Ketorolac Tromethamine Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Ketorolac Tromethamine Sales Value by Application (2021-2032)
  12. 5.3.3 Global Ketorolac Tromethamine Sales Value Share by Application (2021-2032)
6 Ketorolac Tromethamine Regional Sales and Value Analysis
  1. 6.1 Global Ketorolac Tromethamine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ketorolac Tromethamine Sales by Region (2021-2032)
  3. 6.2.1 Global Ketorolac Tromethamine Sales by Region: 2021-2026
  4. 6.2.2 Global Ketorolac Tromethamine Sales by Region (2027-2032)
  5. 6.3 Global Ketorolac Tromethamine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Ketorolac Tromethamine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Ketorolac Tromethamine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Ketorolac Tromethamine Sales Value by Region (2027-2032)
  9. 6.5 Global Ketorolac Tromethamine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Ketorolac Tromethamine Sales Value (2021-2032)
  12. 6.6.2 North America Ketorolac Tromethamine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Ketorolac Tromethamine Sales Value (2021-2032)
  15. 6.7.2 Europe Ketorolac Tromethamine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Ketorolac Tromethamine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Ketorolac Tromethamine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Ketorolac Tromethamine Sales Value (2021-2032)
  21. 6.9.2 South America Ketorolac Tromethamine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Ketorolac Tromethamine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Ketorolac Tromethamine Sales Value Share by Country, 2025 VS 2032
7 Ketorolac Tromethamine Country-level Sales and Value Analysis
  1. 7.1 Global Ketorolac Tromethamine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Ketorolac Tromethamine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Ketorolac Tromethamine Sales by Country (2021-2032)
  4. 7.3.1 Global Ketorolac Tromethamine Sales by Country (2021-2026)
  5. 7.3.2 Global Ketorolac Tromethamine Sales by Country (2027-2032)
  6. 7.4 Global Ketorolac Tromethamine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Ketorolac Tromethamine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Ketorolac Tromethamine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Ketorolac Tromethamine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Ketorolac Tromethamine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Ketorolac Tromethamine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Ketorolac Tromethamine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Ketorolac Tromethamine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Ketorolac Tromethamine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Ketorolac Tromethamine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Ketorolac Tromethamine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Ketorolac Tromethamine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Ketorolac Tromethamine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Ketorolac Tromethamine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Ketorolac Tromethamine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Ketorolac Tromethamine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Ketorolac Tromethamine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Ketorolac Tromethamine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Ketorolac Tromethamine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Ketorolac Tromethamine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Ketorolac Tromethamine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Ketorolac Tromethamine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Ketorolac Tromethamine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Ketorolac Tromethamine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Ketorolac Tromethamine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Ketorolac Tromethamine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Ketorolac Tromethamine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Ketorolac Tromethamine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Ketorolac Tromethamine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Ketorolac Tromethamine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Ketorolac Tromethamine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Ketorolac Tromethamine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Ketorolac Tromethamine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Ketorolac Tromethamine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Ketorolac Tromethamine Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Sun Pharmaceutical
  8. 8.2.1 Sun Pharmaceutical Company Information
  9. 8.2.2 Sun Pharmaceutical Business Overview
  10. 8.2.3 Sun Pharmaceutical Ketorolac Tromethamine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sun Pharmaceutical Ketorolac Tromethamine Product Portfolio
  12. 8.2.5 Sun Pharmaceutical Recent Developments
  13. 8.3 Sandoz
  14. 8.3.1 Sandoz Company Information
  15. 8.3.2 Sandoz Business Overview
  16. 8.3.3 Sandoz Ketorolac Tromethamine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sandoz Ketorolac Tromethamine Product Portfolio
  18. 8.3.5 Sandoz Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Ketorolac Tromethamine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Ketorolac Tromethamine Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Ketorolac Tromethamine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Ketorolac Tromethamine Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 Sagent Pharmaceuticals
  32. 8.6.1 Sagent Pharmaceuticals Company Information
  33. 8.6.2 Sagent Pharmaceuticals Business Overview
  34. 8.6.3 Sagent Pharmaceuticals Ketorolac Tromethamine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Sagent Pharmaceuticals Ketorolac Tromethamine Product Portfolio
  36. 8.6.5 Sagent Pharmaceuticals Recent Developments
  37. 8.7 Omeros Corporation
  38. 8.7.1 Omeros Corporation Company Information
  39. 8.7.2 Omeros Corporation Business Overview
  40. 8.7.3 Omeros Corporation Ketorolac Tromethamine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Omeros Corporation Ketorolac Tromethamine Product Portfolio
  42. 8.7.5 Omeros Corporation Recent Developments
  43. 8.8 Gland Pharma Limited
  44. 8.8.1 Gland Pharma Limited Company Information
  45. 8.8.2 Gland Pharma Limited Business Overview
  46. 8.8.3 Gland Pharma Limited Ketorolac Tromethamine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Gland Pharma Limited Ketorolac Tromethamine Product Portfolio
  48. 8.8.5 Gland Pharma Limited Recent Developments
  49. 8.9 Egalet US Inc.
  50. 8.9.1 Egalet US Inc. Company Information
  51. 8.9.2 Egalet US Inc. Business Overview
  52. 8.9.3 Egalet US Inc. Ketorolac Tromethamine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Egalet US Inc. Ketorolac Tromethamine Product Portfolio
  54. 8.9.5 Egalet US Inc. Recent Developments
  55. 8.10 Dr. Reddy’s Laboratories
  56. 8.10.1 Dr. Reddy’s Laboratories Company Information
  57. 8.10.2 Dr. Reddy’s Laboratories Business Overview
  58. 8.10.3 Dr. Reddy’s Laboratories Ketorolac Tromethamine Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Dr. Reddy’s Laboratories Ketorolac Tromethamine Product Portfolio
  60. 8.10.5 Dr. Reddy’s Laboratories Recent Developments
  61. 8.11 Aurobindo Pharma
  62. 8.11.1 Aurobindo Pharma Company Information
  63. 8.11.2 Aurobindo Pharma Business Overview
  64. 8.11.3 Aurobindo Pharma Ketorolac Tromethamine Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Aurobindo Pharma Ketorolac Tromethamine Product Portfolio
  66. 8.11.5 Aurobindo Pharma Recent Developments
  67. 8.12 Apotex
  68. 8.12.1 Apotex Company Information
  69. 8.12.2 Apotex Business Overview
  70. 8.12.3 Apotex Ketorolac Tromethamine Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Apotex Ketorolac Tromethamine Product Portfolio
  72. 8.12.5 Apotex Recent Developments
  73. 8.13 Amphastar Pharmaceuticals
  74. 8.13.1 Amphastar Pharmaceuticals Company Information
  75. 8.13.2 Amphastar Pharmaceuticals Business Overview
  76. 8.13.3 Amphastar Pharmaceuticals Ketorolac Tromethamine Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Amphastar Pharmaceuticals Ketorolac Tromethamine Product Portfolio
  78. 8.13.5 Amphastar Pharmaceuticals Recent Developments
  79. 8.14 Allergan
  80. 8.14.1 Allergan Company Information
  81. 8.14.2 Allergan Business Overview
  82. 8.14.3 Allergan Ketorolac Tromethamine Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Allergan Ketorolac Tromethamine Product Portfolio
  84. 8.14.5 Allergan Recent Developments
  85. 8.15 Akorn
  86. 8.15.1 Akorn Company Information
  87. 8.15.2 Akorn Business Overview
  88. 8.15.3 Akorn Ketorolac Tromethamine Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Akorn Ketorolac Tromethamine Product Portfolio
  90. 8.15.5 Akorn Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Ketorolac Tromethamine Value Chain Analysis
  2. 9.1.1 Ketorolac Tromethamine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Ketorolac Tromethamine Sales Mode & Process
  6. 9.2 Ketorolac Tromethamine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Ketorolac Tromethamine Distributors
  9. 9.2.3 Ketorolac Tromethamine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst